New therapies targeting aging cells in the skin
Anna Paszel-Jaworska(Poznan University of Medical Sciences), Błażej Rubiś(Poznan University of Medical Sciences), Violetta Krajka‐Kuźniak(Poznan University of Medical Sciences), Aleksandra Gostyńska(Poznan University of Medical Sciences), Maciej Stawny(Poznan University of Medical Sciences), Adriana Polańska(Poznan University of Medical Sciences), Aleksandra Dańczak‐Pazdrowska(Poznan University of Medical Sciences), Michał M. Masternak(University of Central Florida), Justyna Gornowicz‐Porowska(Poznan University of Medical Sciences)
Cited by 0
Related Papers
Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study
|EBioMedicine|2019|1.2k
Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability
|EBioMedicine|2023|275
Vitamin C as a Modulator of the Response to Cancer Therapy
|Molecules|2019|104
Telomerase and drug resistance in cancer
|Cellular and Molecular Life Sciences|2017|102
The non-canonical functions of telomerase: to turn off or not to turn off
|Molecular Biology Reports|2018|61